Why did Trump extend TikTok divestment deadline?
How will Fed rate cut impact markets?
What caused Tesla’s door handle safety probe?
Why is VinFast's US factory construction significant?
What are implications of StubHub IPO pricing?
How is Microsoft investing in UK AI sector?
Why is Cathie Wood buying AMD and Bullish shares?
Novo Nordisk's Rybelsus Now First Oral GLP-1 RA In Europe With Proven Heart Health Impact
benzinga.com/news/health-care/25/09/47675095/novo-nordisks-rybelsus-now-first-oral-glp-1-ra-in-europe-with-proven-heart-health-impact
On Monday, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) approved an update to Novo Nordisk A/S‘ (NYSE:NVO) Rybelsus (oral semaglutide) label to reflect the cardiovascular benefits seen in the SOUL trial.
SOUL was a phase 3b trial carried out…
This story appeared on benzinga.com, 2025-09-15 17:23:07.